Previous Article | Next Article 
Journal of Virology, January 1999, p. 398-403, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of Murine CD8+ T-Cell Clones
Specific for the Dengue Virus NS3 Protein: Flavivirus
Cross-Reactivity and Influence of Infecting Serotype
Anne C.
Spaulding,
Ichiro
Kurane,
Francis A.
Ennis, and
Alan L.
Rothman*
Center for Infectious Diseases and Vaccine
Research, University of Massachusetts Medical Center, Worcester,
Massachusetts 01655
Received 21 July 1998/Accepted 5 October 1998
Serotype-cross-reactive dengue virus-specific cytotoxic T
lymphocytes (CTL) induced during a primary dengue virus infection are
thought to play a role in the immunopathogenesis of dengue hemorrhagic
fever (DHF) during a secondary dengue virus infection. Although there
is no animal model of DHF, we previously reported that murine dengue
virus-specific CTL responses are qualitatively similar to human dengue
virus-specific CTL responses. We used BALB/c mice to study the
specificity of the CTL response to an immunodominant epitope on the
dengue virus NS3 protein. We mapped the minimal
H-2Kd-restricted CTL epitope to residues 298 to
306 of the dengue type 2 virus NS3 protein. In short-term T-cell lines
and clones, the predominant CD8+ CTL to this epitope in
mice immunized with dengue type 2 virus or vaccinia virus expressing
the dengue type 4 virus NS3 protein were cross-reactive with dengue
type 2 or type 4 virus, while broadly serotype-cross-reactive CTL were
a minority population. In dengue type 3 virus-immunized mice, the
predominant CTL response to this epitope was broadly serotype
cross-reactive. All of the dengue virus-specific CTL clones studied
also recognized the homologous NS3 sequences of one or more closely
related flaviviruses, such as Kunjin virus. The critical contact
residues for the CTL clones with different specificities were mapped
with peptides having single amino acid substitutions. These data
demonstrate that primary dengue virus infection induces a complex
population of flavivirus-cross-reactive NS3-specific CTL clones in mice
and suggest that CTL responses are influenced by the viral serotype.
These findings suggest an additional mechanism by which the order of
sequential flavivirus infections may influence disease manifestations.
*
Corresponding author. Mailing address: Center for
Infectious Diseases and Vaccine Research, University of Massachusetts
Medical Center, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-4182. Fax: (508) 856-4890. E-mail:
alan.rothman{at}ummed.edu.

Present address: Department of Virology I, National Institute of
Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640,
Japan.
Journal of Virology, January 1999, p. 398-403, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yauch, L. E., Zellweger, R. M., Kotturi, M. F., Qutubuddin, A., Sidney, J., Peters, B., Prestwood, T. R., Sette, A., Shresta, S.
(2009). A Protective Role for Dengue Virus-Specific CD8+ T Cells. J. Immunol.
182: 4865-4873
[Abstract]
[Full Text]
-
Noisakran, S., Perng, G. C.
(2008). Alternate Hypothesis on the Pathogenesis of Dengue Hemorrhagic Fever (DHF)/Dengue Shock Syndrome (DSS) in Dengue Virus Infection. Exp. Biol. Med.
233: 401-408
[Abstract]
[Full Text]
-
Selin, L. K., Brehm, M. A.
(2007). Frontiers in Nephrology: Heterologous Immunity, T Cell Cross-Reactivity, and Alloreactivity. J. Am. Soc. Nephrol.
18: 2268-2277
[Abstract]
[Full Text]
-
Wang, T., Gao, Y., Scully, E., Davis, C. T., Anderson, J. F., Welte, T., Ledizet, M., Koski, R., Madri, J. A., Barrett, A., Yin, Z., Craft, J., Fikrig, E.
(2006). {gamma}{delta} T Cells Facilitate Adaptive Immunity against West Nile Virus Infection in Mice. J. Immunol.
177: 1825-1832
[Abstract]
[Full Text]
-
Mitaksov, V., Fremont, D. H.
(2006). Structural Definition of the H-2Kd Peptide-binding Motif. J. Biol. Chem.
281: 10618-10625
[Abstract]
[Full Text]
-
Calvert, A. E., Huang, C. Y.-H., Kinney, R. M., Roehrig, J. T.
(2006). Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol.
87: 339-346
[Abstract]
[Full Text]
-
Doisne, J.-M., Urrutia, A., Lacabaratz-Porret, C., Goujard, C., Meyer, L., Chaix, M.-L., Sinet, M., Venet, A.
(2004). CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection. J. Immunol.
173: 2410-2418
[Abstract]
[Full Text]
-
Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R., Harris, E.
(2004). Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical. J. Virol.
78: 2701-2710
[Abstract]
[Full Text]
-
Harvey, T. J., Anraku, I., Linedale, R., Harrich, D., Mackenzie, J., Suhrbier, A., Khromykh, A. A.
(2003). Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development. J. Virol.
77: 7796-7803
[Abstract]
[Full Text]
-
Twiddy, S. S., Woelk, C. H., Holmes, E. C.
(2002). Phylogenetic evidence for adaptive evolution of dengue viruses in nature. J. Gen. Virol.
83: 1679-1689
[Abstract]
[Full Text]
-
Zivna, I., Green, S., Vaughn, D. W., Kalayanarooj, S., Stephens, H. A. F., Chandanayingyong, D., Nisalak, A., Ennis, F. A., Rothman, A. L.
(2002). T Cell Responses to an HLA-B*07-Restricted Epitope on the Dengue NS3 Protein Correlate with Disease Severity. J. Immunol.
168: 5959-5965
[Abstract]
[Full Text]
-
Regner, M., Lobigs, M., Blanden, R. V., Milburn, P., Mullbacher, A.
(2001). Antiviral Cytotoxic T Cells Cross-Reactively Recognize Disparate Peptide Determinants from Related Viruses but Ignore More Similar Self- and Foreign Determinants. J. Immunol.
166: 3820-3828
[Abstract]
[Full Text]
-
Huang, C. Y.-H., Butrapet, S., Pierro, D. J., Chang, G.-J. J., Hunt, A. R., Bhamarapravati, N., Gubler, D. J., Kinney, R. M.
(2000). Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine. J. Virol.
74: 3020-3028
[Abstract]
[Full Text]